Patient and tumor characteristics
Patient . | Sex . | Age . | Primary tumor . | cTNM . | pTNM . |
---|---|---|---|---|---|
1 | F | 57 | Oral cavity, tongue, right | T2N0M0 | T2N1M0 |
2 | M | 57 | Unknown primary, base of tongue right side suspected | TXN2aM0 | TisN2bM0 |
3 | F | 72 | Oropharynx, tonsil, right | T2N2bM0 | T2N2bM0 |
4 | F | 53 | Oropharynx, tonsil, right | T3N0M0 | T3N2bM0 |
5 | M | 63 | Oropharynx, tonsil, right | T4N0M0 | T4N2bM0 |
6 | F | 58 | Oral cavity, alveolar process and floor of mouth, left | T4N0M0 | T4N2bM0 |
7 | M | 54 | Oral cavity, tongue/floor of mouth, right | T3N0M0 | T3N2bM0 |
8 | M | 55 | Oropharynx, tonsil, left | T4N2aM0 | T4N2bM0 |
9 | F | 54 | Hypopharynx, piriform sinus, left | T4N2bM0 | T4N2bM0 |
10 | F | 65 | Oral cavity, base of tongue, right | T2N0M0 | T2N0M0 |
11 | M | 53 | Larynx, glottic | T4N0M0 | T4N0M0 |
12 | M | 59 | Larynx, supraglottic | T4N0M0 | T4N0M0 |
13 | F | 49 | Residual disease after T2N0 tonsil carcinoma, left | NA | NA |
14 | M | 58 | Oropharynx, base of tongue, right | T2N2bM0 | T2N2bM0 |
15 | M | 48 | Oropharynx, tonsil, right | T3N0M0 | T3N1M0 |
16 | F | 63 | Oropharynx, tonsil, left | T3N2bM0 | T3N2b/cM0 |
17 | M | 53 | Oropharynx, tonsil, right | T2N3M0 | T2N3M0 |
18 | M | 58 | Larynx, supraglottic, recurrence | NA | NA |
19 | M | 71 | Oropharynx, soft palate, right | T3N2cM0 | T2N2cM0 |
20 | M | 60 | Larynx, supraglottic, recurrence | NA | NA |
Patient . | Sex . | Age . | Primary tumor . | cTNM . | pTNM . |
---|---|---|---|---|---|
1 | F | 57 | Oral cavity, tongue, right | T2N0M0 | T2N1M0 |
2 | M | 57 | Unknown primary, base of tongue right side suspected | TXN2aM0 | TisN2bM0 |
3 | F | 72 | Oropharynx, tonsil, right | T2N2bM0 | T2N2bM0 |
4 | F | 53 | Oropharynx, tonsil, right | T3N0M0 | T3N2bM0 |
5 | M | 63 | Oropharynx, tonsil, right | T4N0M0 | T4N2bM0 |
6 | F | 58 | Oral cavity, alveolar process and floor of mouth, left | T4N0M0 | T4N2bM0 |
7 | M | 54 | Oral cavity, tongue/floor of mouth, right | T3N0M0 | T3N2bM0 |
8 | M | 55 | Oropharynx, tonsil, left | T4N2aM0 | T4N2bM0 |
9 | F | 54 | Hypopharynx, piriform sinus, left | T4N2bM0 | T4N2bM0 |
10 | F | 65 | Oral cavity, base of tongue, right | T2N0M0 | T2N0M0 |
11 | M | 53 | Larynx, glottic | T4N0M0 | T4N0M0 |
12 | M | 59 | Larynx, supraglottic | T4N0M0 | T4N0M0 |
13 | F | 49 | Residual disease after T2N0 tonsil carcinoma, left | NA | NA |
14 | M | 58 | Oropharynx, base of tongue, right | T2N2bM0 | T2N2bM0 |
15 | M | 48 | Oropharynx, tonsil, right | T3N0M0 | T3N1M0 |
16 | F | 63 | Oropharynx, tonsil, left | T3N2bM0 | T3N2b/cM0 |
17 | M | 53 | Oropharynx, tonsil, right | T2N3M0 | T2N3M0 |
18 | M | 58 | Larynx, supraglottic, recurrence | NA | NA |
19 | M | 71 | Oropharynx, soft palate, right | T3N2cM0 | T2N2cM0 |
20 | M | 60 | Larynx, supraglottic, recurrence | NA | NA |
Abbreviations: TNM, tumor-node-metastasis system; cTNM, clinical classification; pTNM, pathologic classification; NA, not applicable.